University College London: Centre for Amyloidosis and Acute Phase Proteins | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: People & Places

Healthcare providers, researchers, and advocates

Back to Places / Academic & Health Care Centers
University College London: Centre For Amyloidosis And Acute Phase Proteins

University College London: Centre for Amyloidosis and Acute Phase Proteins

Division of Medicine (Royal Free Campus)
University College London
Rowland Hill Street
London, United Kingdom
Email   Phone   Web  

The Centre for Amyloidosis and Acute Phase Proteins comprises the NHS National Amyloidosis Centre, funded by the Department of Health, to provide diagnostic and management advisory services for the national caseload of patients with amyloidosis and hereditary periodic fever syndromes, and the Wolfson Drug Discovery Unit. These teams undertake world leading, wide ranging, basic and clinical research on amyloid and amyloidosis, C‑reactive protein and serum amyloid a protein, leading to design and development of new treatments.

The Centre conducts world leading research in all aspects of the pentraxin family of plasma proteins, and in amyloidosis. Studies range from molecular, genetic, biochemical, physiological and pathological investigations to clinical diagnostics, patient management and new drug discovery. There are extensive collaborative links with scientists, clinicians and industry in many of these areas.

The team includes healthcare professionals in the following areas:

Hematology and Oncology:
Ashutosh Wechalekar, MBBS, MD, FRCP, FRCPath, DM

Rheumatology:
Prof. Philip Hawkins, FMedSci

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2024 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close